2011, Oct-15^th (Sat)

12:30-13:30

Welcome lunch

13:30-13:35

Welcome address

Malcolm Allison(Bayer)

13:35-13:40

Opening remarks

Hojoong Kim (Korea)

Session-1: What’s new in PAH? 

Kuo-Yang Wang (Taiwan)

13:40-14:00        

Assessment of PAH using cardiac MRI

Hyuk-Jae Chang (Korea)

14:00-14:20

Medium to long term effects of aerosolized iloprost in patients with pulmonary hypertension

Xin Jiang (China)

14:20-14:40

Role of inhaled iloprost in severe PH in adult CHD

 Cao-Jin Zhang (China)

14:40-15:00

Current challenges in treating PAH in CTD

Chin-Chang Cheng (Taiwan)

15:00-15:30

Drug therapy of PAH – Current & future

Henning Tiede (Germany)

15:30-15:50

Coffee Break

Session-2: Current practices in PH care: Initiatives in Asian countries

Duk-Kyung Kim (Korea)

15:50-16:10

Korea: Current PH diagnosis and treatment status in Korea

Hye-Sun Seo (Korea)

16:10-16:30

China: The new registry study in China

Zhi-Cheng  Jing (China)

16:30-16:50

Taiwan: Development of PH diagnosis, treatment recommendation and reimbursement status in Taiwan

Kuo-Yang Wang (Taiwan)

16:50-17:10

Japan: Local experience with combination therapy

Yoshihiro Fukumoto (Japan)

17:10-17:40

Panel Discussion: Steps toward better treatment options in PH

Hye-Sun Seo (Korea)

Zhi-Cheng Jing (China)

Kuo-Yang Wang  (Taiwan)

Yoshihiro Fukumoto (Japan)

Hojoong Kim (Korea)

17:40-17:50

Day 1 closing remarks

Hojoong  Kim (Korea)

17:50-18:30

Break

18:30-21:30

Dinner

Malcolm Allison (Bayer)

2011, Oct-16^th (Sun)

Day 2 opening remarks

 Malcolm Allison (Bayer)

Session-3: Research Updates in Non-PAH PH

Hojoong Kim (Korea)

8:30-8:50        

PH in ILD

Nick Kim (US)

8:50-9:10

PH in COPD

 Jin-Hwa Lee
(Korea)

9:10-9:30

CTEPH: Real practices in Japan

Masaru Hatano(Japan)

9:30-9:50

CTEPH: Role of Medical Therapy

Nick Kim (US)

9:50-10:10

Coffee Break

Session-4: Frontline Research in PH treatment

Zhi-Cheng Jing (China)

10:10-10:30

Predicting therapeutic effectiveness of PDE5Is in iPAH with Arterial Methemoglobin

Yuichi Tamura (Japan)

10:30-10:50

Importance of cGMA pathway in PAH - Insights from preclinical models

Steve Leu (Taiwan)

10:50-11:10

Acute pulmonary vasodilator testing for preoperative assessment of surgical operability of CHD with severe PH

Hong Gu (China)

11:10-11:30

Chinese expert consensus in pediatric CHD-PAH

Zhuo-Ming Xu (China)

11:30-11:50

Case-based approach of pulmonary hypertension in children and adolescents

Gi-Beom Kim  (Korea)

11:50-12:10

Hemodynamics in PH: The Role of Echocardiography and Right Heart Catheterization

Sung-A Chang (Korea)

12:10-12:20

Closing remarks

Kuo-Yang Wang (Taiwan)
Malcolm  Allison (Bayer)

12:20-13:30

Lunch (Optional)